Trial Profile
Quality of Life With TESTIM in Testosterone Replacement Therapy for Male Patients With Hypogonadism.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 21 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Dec 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
- 13 Apr 2011 Planned end date changed from 1 Jun 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.